潘普洛纳生物科技

Pamplona Biotech is an innovative biotechnology company headquartered in Shanghai, China, dedicated to the discovery and development of breakthrough small molecule therapeutics. The company specializes in the field of targeted protein degradation, utilizing its proprietary platform to design PROTACs and molecular glues that address previously "undruggable" targets. Founded in 2020 by a team of seasoned industry veterans with extensive global R&D experience, Pamplona Biotech focuses on high-value pathways in oncology and immunology. The company has successfully secured significant venture capital funding from top-tier investors to advance its internal pipeline toward clinical trials. Its mission is to provide transformative treatment options for patients with life-threatening diseases and significant unmet medical needs.